The full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or charge, for personal research or study, educational, or not-for-prot purposes provided that:
Introduction
In the field of bioinorganic chemistry, platinum group metal complexes have found application in cellular imaging, 1 in enzyme inhibition 2 and as molecular probes of biological activity. 3 The therapeutic anticancer activity these complexes is also often probed both in vitro and in vivo. 4 In the context of therapeutics, the advantages that metal complexes offer over purely organic species include: a variety of metal geometries and coordination numbers, allowing access to intricate 3-dimensional structures; numerous metal oxidation states, allowing redox-activated drugs; tuneable ligands to vary sterics and electronics about the metal centre; exchangeable ligands, for in situ activation and binding to biomolecules; simple and modular syntheses, allowing rapid determination of structure to activity relationships. Despite the wide-spread clinical use of the platinum-based drugs, cisplatin, oxaliplatin and carboplatin, 5 there remains issues associated with side-effects, including dose-limiting systemic toxicities 6 and acquisition of drug resistance, which reduce the efficacy and clinical utility of these drugs. 7 One class of metal complexes that has shown great promise as alternatives to Pt drugs are the pseudo-octahedral piano stool complexes, 8 in which a low-spin d 6 metal ion is capped by an η 6 -phenyl or η 5 -cyclopentadienyl ligand, with the remaining 3 coordination sites occupied by tri-bi-or mono-dentate ligands.
Over the past decades, many examples of piano stool metal complexes have been reported that show excellent in vitro 9 and in vivo 10 activity against cancers ( Figure 1 ). Variation of each component of the piano stool arrangement alters the activity of the complex. For example, in the series [(η 6 -arene)Ru(en)Cl]PF 6 a 3-fold increase in activity against human ovarian cancer cell line A2780 is observed when the arene is varied from benzene to biphenyl.
11
Similarly, modulation of the mono-dentate halide in the series [(η 6 -p-cym)Ru(p-Azpy-NMe 2 )X]PF 6 from chloride to iodide results in a decrease in IC 50 , the concentration of complex required to inhibit cell proliferation by 50%, from 13 μM to 0.69 μM in the A2780 cell line. 12 The vast majority of reported piano stool complexes in the bioinorganic chemistry field incorporate polypyridyl, carboxylate or halide ligands. Only rarely are ligands explored that include elements other than C, N and O. However, there are a host of alternatives that may offer significant advantages over the more traditional ligand systems. In this study we present a novel ligand for platinum group metal complexes: the pyridylphosphinates. We report the synthesis, structural characterisation, aqueous properties and biological activities, including in vitro cytotoxicities, of a series of piano stool metal complexes incorporating the pyridylphosphinate ligand (Figure 1 ). Lanthanide complexes incorporating this ligand have found application in cellular imaging. 20 However, the piano stool pyridylphosphinate complexes have never been studied. Advantages of the pyridylphosphinate ligand include: biocompatibility; the presence of a 31 P-NMR spectroscopic handle; control over lipophilicity at phosphorus; modular synthesis allowing rapid structure-activity relationship profile and, finally, the presence a stereogenic phosphorus, which presents an opportunity to develop enantiomerically pure metalbased complexes.
21
Despite the host of piano stool complexes that have been reported, there is often a lack of information on biological behaviour, such as interactions between biologically relevant molecules (amino acids, proteins and nucleobases) and the metal complexes. This information is needed as the changes in structure of the complexes that take place in the cellular environment will have a profound effect upon the biological activity. Herein, we interrogate the behaviour of the novel pyridylphosphinate complexes in biological systems, by monitoring metal-halide hydrolysis, measuring pK a values of the resultant aqua complexes and carrying out detailed binding studies with selected biomolecules.
Synthesis and Structural Characterisation
A series of complexes were synthesised in order to assess the factors that determine aqueous biological behaviour. Systematic variation in the metal-arene combination, the metal-bound halide, the phosphorus R' group and the pyridyl R group led to a library of 25 new compounds (Scheme 1). Synthesis involves Pd-catalysed coupling of the phosphinate (HPO(OEt)R') and bromo-pyridyl precursors.
22 Quantitative hydrolysis of the phosphinate ester was followed by neutralisation with NaOMe and complexation with the appropriate metal dimer [(arene)MX 2 ] 2 . Purification by recrystallisation from CHCl 3 /Et 2 O gave the final complexes with 30-50% yields. †
The synthesis of complexes 7 and 8 (Scheme 2) proceeds via the 4-fluoropyridylphosphinate intermediate L1, which undergoes nucleophilic aromatic substitution to form the electron-rich 4-OCD 3 -or electron-poor 4-Cl-pyridylphosphinate ligand, depending upon hydrolysis conditions.
Single crystals suitable for X-ray diffraction studies were grown of complexes 3 and 20 (Figures 2A and 3 ). Complex 3 crystallises in the monoclinic crystal system and the P2 1 /c space group and displays the expected pseudo-tetrahedral geometry, with the η 6 -pcymene occupying one vertex. Ru-Cl (2.4155(6) Å), Ru-O (2.0809(14) Å) and Ru-N (2.1109(17) Å) bond lengths are almost identical to those reported for the analogous picolinate complex [(η 6 -p-cym)Ru(picolinate)Cl], 13 however, the N-Ru-O bite angle is slightly larger in complex 3, at 80.50(6)° (bite angle in picolinate complex is 77.95(7)°), reflecting the larger size of the phosphinate group. Intriguingly, of the four possible stereoisomers (R or S at Ru and P, denoted Ru R/S and P R/S , respectively), only one enantiomeric pair is observed in the solid state structure -Ru S P R and Ru R P S . 1 H-NMR indicates that a single diastereomer is also present in solution, evidenced by one set of diastereotopic p-cymene protons in the region 5 -6 ppm ( Figure 2B ). The origin of this stereoselectivity, which has also been observed in lanthanide pyridylphosphinate complexes, 23 can be rationalised in terms of the steric interactions between the p-cymene ligand and the P-phenyl group, which are
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Please do not adjust margins Please do not adjust margins minimised in the observed diastereomer. Weak intramolecular hydrogen bonds between the P=O and p-cymene methyl-H (2.587 Å) and the P-phenyl and pyridyl methyl-H (3.065 Å) may also influence the observed stereochemistry. In solution, slight broadening of the pyridyl Me peak reflects its proximity to the Pphenyl aromatic system, but the presence of a sharp singlet peak for the p-cymene Me group suggests free rotation of the p-cymene ligand, as is expected for η 6 -arene-metal bonds. 24 The solid state structure of the Cp*-Ir complex 20 (Figure 3 ) shows several differences from complex 3, including a Cc space group, longer bond lengths between the central metal and coordinated ligands and a wider N-metal-O bite angle of 82.00(11)°. Despite the presence of the less sterically challenging Pmethyl phosphinate ligand, once again only a single diastereoisomer is observed -Ir S P R and Ir R P S . No intramolecular Hbond interactions can be observed in the crystal structure, which presents further questions over the origin of this stereoselectivity. It may be that stereoselectivity originates from the initial attack of the phosphinate ligand on the metal dimer, during the formation of the complex.
Aqueous Behaviour of the Complexes
To gain an understanding of the intracellular behaviour of metal complexes with biological application, it is essential to have an appreciation of the aqueous behaviour of new compounds. Upon dissolving complex 1 in a D 2 O : CD 3 OD (9 : 1) mix, equilibrium is established between the chloride (complex 1) and aqua (complex Figure 4A ). To confirm that the observed species are the chloride and aqua adducts, the complex was dissolved in 100 mM NaCl ( Figure 4B ) and in aqueous AgNO 3 , followed by filtration of AgCl ( Figure 4C ), leading to the selective formation of the chloride and aqua adducts, respectively, each showing a characteristic set of diastereotopic protons. The analogous Ru-iodide complex also undergoes rapid hydrolysis with around 60% of the complex remaining as the intact iodide species.
At the extracellular chloride concentration (approx. 100 mM), the pyridylphosphinate complexes remains intact as the chloride adduct, but at lower intracellular chloride concentration (approx. 20 mM in cytoplasm) 25 significant amounts of the aqua adduct are present. With this in mind, we sought to measure the pK a of the bound water molecule and to establish how the pK a varies with the H-NMR spectra (D2O : CD3OD 9:1, 298 K, 400 MHz) of (A) complex 1 and 1a at approximately 1:1 equilibrium ratio, (B) chloride complex 1, following addition of 100 mM NaCl and (C) aqua complex 1a, following addition of AgNO3 and filtration of AgCl. Please do not adjust margins Please do not adjust margins . pK a * values were converted to pK a values using the equation pK a = 0.929pK a * + 0.42. 26 By comparing pK a values of selected aqua complexes (Table 1) , it is apparent that a more electron donating pyridyl ligand leads to a higher pK a . This is shown by the increase in values in the order 5a < 3a < 7a for complexes with 4-Me, 3-Me and OCD 3 pyridyl substituents, respectively. This order reflects the higher pH required to deprotonate H 2 O bound to a more electronrich metal centre. The phosphorus-bound R' group has little effect on pK a , as can be seen by comparing values for 3a and 4a. Finally, as expected, the pK a value for the Ir complex 20a is lower than that of the equivalent Rh complex 25a, reflecting the increased metaloxygen bond strength of the heavier congener. 27 For each of the studied Ru complexes, the hydroxyl-bridged dimer D1 ( Figure 5 ) forms at strongly basic pH (typically >pH 11), with concomitant loss of the pyridylphosphinate ligand.
† The formation of this dimeric species from Ru piano stool complexes at elevated pH has been observed previously and the dimer is known to be non-cytotoxic. 28 NMR experiments indicate that dimer formation is partially reversible upon lowering the pH, but that complete regeneration of the starting complex does not take place. 
Cytotoxicity Studies
The toxicity of each complex was assessed against non-small cell lung carcinoma H460 cells. Each complex was incubated with H460 cells for 96 h at concentrations ranging from 0.1 to 200 μM (aqueous media containing 0.1% DMSO) and IC 50 values were measured using the MTT assay (see ESI † for details). The solubility of complexes at these concentrations was assessed to ensure the compounds are fully dissolved (see ESI † for details). Selected results are shown in Table 2 and represent the mean value for data from at least three experiments. All Ru complexes incorporating chloride ligands are non-toxic up to 200 μM. The most cytotoxic species are the iridium-Cp* complexes 21 and 22, each with IC 50 values of 50 ± 5 μM, respectively. The presence of the iodide ligand appears to play an important role in the observed toxicity, as the analogous chloride complexes, 18 and 19, gave IC 50 values >200 μM. Comparing complexes 21 (P-phenyl) and 22 (P-methyl), it would appear that the phosphorus-R group has little influence upon the toxicity. However, this is not the case when comparing the Ru-pcymene complexes 10 and 11, for which the P-phenyl analogue has significantly greater cytotoxicity than the P-methyl complex. A comparison with cisplatin (IC 50 = 0.80 ± 0.01 under the experimental conditions), shows that in general this class of complexes have low cytotoxicity. While ineffective as cytotoxic agents, this feature may bode well for uses in applications such as enzyme inhibitors.
A general feature within this series is that the complexes incorporating monodentate iodide ligands have higher toxicities than the corresponding chloride complexes. The extent of hydrolysis of the iodide complexes is less than that of the chloride complexes, leading to the conclusion that a mechanism of action involving hydrolysis and DNA binding, as is often proposed for piano stool metal complexes, may not be the main mechanism of action operating for this series of complexes. Whatever the mechanism, the observation of higher toxicity for iodide complexes is consistent with previously published reports 12, 30 for both Ru-and Os-based anticancer complexes. Studies are ongoing to elucidate a potential mechanism of action for these species.
Binding Studies
In general, the Ru complexes herein have IC 50 values greater than 200 μM. In an attempt to understand this low cytotoxicity, binding studies were carried out with several biomolecules. Addition of Table 3 .
AgNO 3 to complex 1 dissolved in D 2 O, followed by filtration of the resulting AgCl precipitate, gave the aqua adduct, 1a. Mass spectrometry and NMR spectroscopy ( 1 H and 31 P) were used to identify the presence and extent of biomolecule binding after addition of one and two equivalents of biomolecule to 1a, at 1 h and 16 h time-points ( Figure 6 and Table 3 ). The biomolecules selected for investigation were L-alanine (L-Ala), L-threonine (L-Thr), L-histidine (L-His), imidazole and 9-ethylguanine (9-EtG). No evidence for binding between 1a and 1 equivalent of amino acids LAla and L-Thr was observed after 1 h. In contrast, addition of 1 equivalent of 9-EtG led to a peak in the mass spectrum corresponding to the 9-EtG adduct of 1a, following loss of H 2 O. 1 H-NMR analysis indicated the formation of a bond between Ru and N7 on 9-EtG, with around 50% bound complex in solution. This mode of binding is consistent with previous reports that have proposed a mechanism of action for the anticancer behaviour of Ru complexes to involve DNA binding, leading to apoptosis. 16 Upon addition of 1 equivalent of L-His, an adduct was observed, consistent with replacement of H 2 O for L-His, binding though an imidazole N. When the sample was subjected to a second equivalent of L-His and left to equilibrate over 16 h, a species formed in which the pyridylphosphinate ligand is displaced and the L-His binds κ 3 (Figure 7 ). The observed Ru-(L-His) complex, 1c, is known to be non-cytotoxic 31 and its formation presents a potential explanation of the low cytotoxicity of Ru chloride complexes described in this report. It follows that the higher cytotoxicity of the iodide-complexes, 10, 21 and 22, is due to the metal-iodide bond being less labile towards aquation and therefore less likely to undergo decomplexation by chelating biomolecules. It should be noted that the only tested biomolecule able to displace the pyridylphosphinate ligand was L-His. Addition of 2 equivalents of imidazole (16 h) leads to 1 : 1 adduct formation, with loss of H 2 O, but no ligand displacement. The cytotoxicity of the displaced ligand of complex 1 (shown in Fig 7A) was assessed using the MTT assay and found to by non-cytotoxic up to 200 μM. In future studies it may be possible to tune the lability of pyridylphosphinate ligands, Table 3 Proposed species that give rise to mass peaks in Figure 6 , upon addition of selected biomolecules. Tabulated m/z values a -f correspond to mass peaks in Figure 6 . so that the complexes remain intact in the high chloride concentration of the extracellular medium but are able to release some useful payload within the cell where the chloride concentration is lower.
Conclusions
A series of 25 new piano-stool pyridylphosphinate complexes has been synthesised, characterised and assessed in biologicallyrelevant systems. The properties of the complexes depend upon their various components -metal ion, arene, pyridyl substituent and P-alkyl group -which can be varied with relative ease. Aqueous solubility and stability is good. Ru-Cl complexes are nontoxic up to 200 μM, which bodes well for their use as a scaffold for metal-based enzyme inhibitors. Ir-I complexes are more toxic to cells, so may have the potential to act as anticancer agents, Please do not adjust margins
Please do not adjust margins although toxicity remains low compared to cisplatin. It was discovered that decomplexation of the ligand from complex 1 occurs in the presence of excess L-His, following hydrolysis of the Ru-Cl bond. This has the potential to be exploited in the form of complexes that deliver and release useful payloads to the cell. The rate of aquation and the pK a of the resulting aqua species can be tuned by varying the pyridyl substiuent and the judicious choice of metal-halide combination. Studies are ongoing to investigate the cell uptake, localisation and any potential antimetastatic behaviour of these exciting new complexes and to exploit the lability of the phenylphosphinate Ru bond to design responsive biologically active complexes.
